I-Mab Biopharma
IMAB
#9469
Rank
ยฃ42.97 M
Marketcap
ยฃ0.53
Share price
-6.87%
Change (1 day)
-63.58%
Change (1 year)

I-Mab Biopharma (IMAB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ11.47 Million

According to I-Mab Biopharma's latest financial reports the company's total liabilities are ยฃ11.47 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

I-Mab Biopharma - Total liabilities on balance sheet (from 2024 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ14.01 M-30.66%
2022-12-31ยฃ20.21 M6.4%
2021-12-31ยฃ18.99 M56.16%
2020-12-31ยฃ12.16 M-79.33%
2019-12-31ยฃ58.85 M6.1%
2018-12-31ยฃ55.47 M140.29%
2017-12-31ยฃ23.08 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ9.42 M-17.85%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.64 B 5,540.68%๐Ÿ‡บ๐Ÿ‡ธ USA